PeptideDB

OTs-C6-OBn 126519-80-0

OTs-C6-OBn 126519-80-0

CAS No.: 126519-80-0

OTs-C6-OBn is a PROTAC (PROteolysis TArgeting Chimera) linker of the alkyl chain category. OTs-C6-OBn may be utilized to
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

OTs-C6-OBn is a PROTAC (PROteolysis TArgeting Chimera) linker of the alkyl chain category. OTs-C6-OBn may be utilized to prepare PROTAC SGK3 degrader-1.

Physicochemical Properties


Molecular Formula C13H20O2.C7H8O3S
Molecular Weight 380.49832
Exact Mass 380.166
CAS # 126519-80-0
PubChem CID 15525438
Appearance Colorless to light yellow liquid
LogP 5.078
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 11
Heavy Atom Count 25
Complexity 429
Defined Atom Stereocenter Count 0
SMILES

CC1C=CC(S(O)(=O)=O)=CC=1.C1(COCCCCCCO)C=CC=CC=1

InChi Key VVUMHKDBEGSVMR-UHFFFAOYSA-N
InChi Code

InChI=1S/C20H26O4S/c1-18-11-13-20(14-12-18)25(21,22)24-16-8-3-2-7-15-23-17-19-9-5-4-6-10-19/h4-6,9-14H,2-3,7-8,15-17H2,1H3
Chemical Name

6-phenylmethoxyhexyl 4-methylbenzenesulfonate
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro One ligand is for an E3 ubiquitin ligase, and the other is for the target protein; these two ligands are joined by a linker to form PROTACs. The intracellular ubiquitin-proteasome system is utilized by PROTACs to specifically destroy target proteins[1].
References

[1]. Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader. ACS Chem Biol. 2019 Sep 20;14(9):2024-2034.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~275.88 mM)
Solubility (In Vivo) Solubility in Formulation 1: 2.5 mg/mL (6.90 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (6.90 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6281 mL 13.1406 mL 26.2812 mL
5 mM 0.5256 mL 2.6281 mL 5.2562 mL
10 mM 0.2628 mL 1.3141 mL 2.6281 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.